Funding for this research was provided by:
Received: 18 January 2019
Accepted: 18 March 2019
First Online: 3 April 2019
Ethics approval and consent to participate
: The study protocol was approved by the Ethics Committee Vaud (2015-00010) and registered atExternalRef removed(NCT02775123). Signed informed consent for study participation was obtained from all patients before enrolment into the trial.
: All patients enrolled in this trial consented for anonymous utilisation of the data in the form of a scientific publication.
: AS has received a grant from the Leenaards foundation. He has received speaker honoraria from Cytosorbent SA. All other authors stated that they have no conflict of interest to declare.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.